Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8 T cell activation in the presence of adjuvant temozolomide
/in Dendritic Cells, Glioblastoma, International Publications /von 2018-01-29 / Oncoimmunology 2018;7(4):e1412901Advances in immunotherapeutic research for glioma therapy
/in Dendritic Cells, Glioblastoma, International Publications /von 2017-12-05 / J. Neurol. 2018 Apr;265(4):741-756Clinical and economic evaluation of modulated electrohyperthermia concurrent to dose-dense temozolomide 21/28 days regimen in the treatment of recurrent glioblastoma: a retrospective analysis of a two-centre German cohort trial with systematic comparison and effect-to-treatment analysis
/in Glioblastoma, Hyperthermia, International Publications /von 2017-11-03 / BMJ Open 2017 Nov;7(11):e017387Co-delivery of tumor-derived exosomes with alpha-galactosylceramide on dendritic cell-based immunotherapy for glioblastoma
/in Dendritic Cells, Exosome, Glioblastoma, International Publications /von 2017-09-23 / Cancer Lett. 2017 12;411:182-190Curing glioblastoma: oncolytic HSV-IL12 and checkpoint blockade
/in Checkpoint-Inhibitors, Glioblastoma, International Publications, Newcastle Disease Virus /von 2017-09-20 / Oncoscience 2017 Jul;4(7-8):67-69Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade
/in Checkpoint-Inhibitors, Glioblastoma, International Publications, Newcastle Disease Virus /von 2017-08-14 / Cancer Cell 2017 08;32(2):253-267.e5Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockade
/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2017-07-19 / Int J Cancer 2017 11;141(9):1891-1900Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma
/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications /von 2017-06-01 / Neuro-oncology 2017 06;19(6):796-807Prospect of Immunotherapy for Glioblastoma: Tumor Vaccine, Immune Checkpoint Inhibitors and Combination Therapy
/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications /von 2017-05-24 / Neurol. Med. Chir. (Tokyo) 2017 Jul;57(7):321-330
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution